ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AF10 | G | Entecavir - 0.5mg | 10822 | 90618/1 | APO-ENTECAVIR | 0.5mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 28,943,287 L.L | 19.35 | D | Apotex Inc | Canada | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AF10 | G | Entecavir monohydrate - 0.5mg | 10711 | 49519/1 | AVIRAVIR | 0.5mg | 30 | Tablet, film coated | Oral | BroadMed SAL | Pharmactive Ilac San. ve Tic. AS | Turkey | 32,224,230 L.L | 19.35 | D | Pharmactive Ilac San. ve Tic. AS | Turkey | 2/5/2024 | 0 |
J05AF10 | G | Entecavir - 0.5mg | 10689 | 151919/1 | ENTECAVIR ARROW | 0.5mg | 30 | Tablet, coated | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 18,701,506 L.L | 19.35 | D | Arrow Génériques | France | 2/5/2024 | 0 |
J05AF10 | G | Entecavir - 0.5mg | 10134 | 161819/1 | ENTECAVIR BIOGARAN | 0.5mg | 30 | Tablet, coated | Oral | Commercial and Trading Ressources SAL (CTR) | Remedica Ltd | Cyprus | 19,080,319 L.L | 19.35 | D | Laboratoires Biogaran | France | 2/5/2024 | 0 |
J05AF10 | G | Entecavir - 0.5mg | 10633 | 30120/1 | ENTRILIV | 0.5mg | 30 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 19,165,898 L.L | 19.35 | D | Hexal AG | Germany | 2/5/2024 | 0 |
J05AF10 | G | Entecavir monohydrate - 0.5mg | 10352 | 38614/1 | HEPCAVIR 0.5 | 0.5mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 18,998,515 L.L | 19.35 | D | 2/5/2024 | 0 |